Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-ras (Q61 L) contributes to cell survival

Journal of Cellular Biochemistry

Volumn 88, Issue 1, 2003, Pages 191-204

  Xin, Hong ^a   Geng, Yanbiao ^a   Pramanik, Rocky ^a   Choubey, Divaker ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

c Jun AP 1; Cell survival; H Ras; Interferon inducible p202; p21; Transformation

Indexed keywords

INTERFERON INDUCIBLE P202; PHOSPHOPROTEIN; PROTEIN P21; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; CELL STRAIN 3T3; CELL SURVIVAL; CELL TRANSFORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; APOPTOSIS; BINDING SITES; BLOTTING, NORTHERN; CARRIER PROTEINS; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CYTOPLASM; FLOW CYTOMETRY; GENES, RAS; GENES, REPORTER; GENETIC VECTORS; IMMUNOBLOTTING; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPROTEINS; PLASMIDS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS P21(RAS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSFECTION;

EID: 0037216328     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10372     Document Type: Review

References (43)

1. Amanatullah DF, Zafonte BT, Albanese C, Fu M, Messiers C, Hassell J, Pestell RG. 2001. Ras regulation of cyclin D1 promoter. Methods Enzymol 333:116-127.
2. Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. 1998. Increasing complexity of Ras signaling. Oncogene 17:1395-1413.
3. Choubey D. 2000. p202: An interferon-inducible negative regulator of cell growth. J Biol Regul Homeost Agents 14:187-192.
4. Choubey D, Gutterman JU. 1997. Inhibition of E2F-4/DP-1stimulated transcription by p202. Oncogene 15:291-302.
5. Choubey D, Kotzin BL. 2002. Interferon-inducible p202 in the susceptibility to systemic lupus. Front Biosci 7: E252-E262.
6. Choubey D, Lengyel P. 1993. Interferon action: Cytoplasmic and nuclear localization of the interferon-inducible 52 kD protein that is encoded by the Ifi 200 gene from the gene 200 cluster. J Interferon Res 13:43-52.
7. Choubey D, Lengyel P. 1995. Binding of an interferoninducible protein (p202) to the retinoblastoma protein. J Biol Chem 270:6134-6140.
8. Choubey D, Snoddy J, Chaturvedi V, Toniato E, Opdenakker G, Thicker A, Samantha H, Engel D, Lengyel P. 1989. Interferons as gene activators. Indications for repeated gene duplication during the evolution of a cluster of interferon-activatable genes on murine chromosome 1. J Biol Chem 264:17182-17189.
9. Choubey D, Li SJ, Datta B, Gutterman JU, Lengyel P. 1996. Inhibition of E2F-mediated transcription by p202. EMBO J 15:5668-5678.
10. Clark GJ, O'Bryan JP, Der CJ. 2000. In: Gutkind JS, editor. Signaling Networks and Cell Cycle Control. Totawa, NJ; Humana Press.
11. D'Souza S, Xin H, Walter S, Choubey D. 2001. The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53mediated transcriptional repression. J Biol Chem 276:298-305.
12. Datta B, Li B, Choubey D, Nallur G, Lengyel P. 1996. p202, an interferon-inducible modulator of transcription, inhibits transcriptional activation by the p53 tumor suppressor protein, and a segment from the p53-binding protein 1 that binds to p202 overcomes this inhibition. J Biol Chem 271:27544-27557.
13. Datta B, Min W, Burma S, Lengyel P. 1998. Increase in p202 expression during skeletal muscle differentiation: Inhibition of MyoD protein expression and activity by p202. Mol Cell Biol 18:1074-1083.
14. Deng T, Karin M. 1994. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK. Nature 371:171-175.
15. Downward J. 1998. Ras signalling and apoptosis. Curr Opin Genet Dev 8:49-54.
16. Geng Y, D'Souza S, Xin X, Walter S, Choubey D. 2000. p202 levels are negatively regulated by serum growth factors. Cell Growth Differ 11:475-483.
17. Gutterman JU, Choubey D. 1999. Retardation of cell proliferation after expression of p202 accompanies an increase in p21(WAF1/CIP1). Cell Growth Differ 10:93-100.
18. Hertel L, Rolle S, De Andrea M, Azzimonti B, Osello R, Gribaudo G, Gariglio M, Landolfo S. 2000. The retinoblastoma protein is an essential mediator that links the interferon-inducible 204 gene to cell-cycle regulation. Oncogene 19:3598-3608.
19. Jacobsen K, Groth A, Willumsen BM. 2002. Ras-inducible immortalized fibroblasts: Focus formation without cell cycle deregulation. Oncogene 21:3058-3067.
20. Karin M. 1995. The regulation of AP-1 activity by mitogenactivated protein kinases. J Biol Chem 271:16483-16486.
21. Koul D, Lapushin R, Xu HJ, Mills GB, Gutterman GU, Choubey D. 1998. p202 prevents apoptosis in murine AKR-2B fibroblasts. Biochem Biophys Res Commun 247:379-382.
22. Lin HJ, Eviner V, Prendergast GC, White E. 1995. Activated H-Ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest. Mol Cell Biol 15:4536-4544.
23. Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF. 1995. Ras transformation results in an elevated level of cyclin D1 and acceleration of G1 progression in NIH 3T3 cells. Mol Cell Biol 15:3654-3663.
24. Lloyd AC. 1998. Ras versus cyclin-dependent kinase inhibitors. Curr Opin Genet Dev 8:43-48.
25. Lloyd AC, Obermuller F, Staddon S, Barth CF, McMahon M, Land H. 1997. Cooperating oncogenes converge to regulate cyclin/cdk complexes. Genes Dev 11:663-677.
26. Malumbres M, Pellicer A. 1998. RAS pathways to cell cycle control and cell transformation. Front Biosci 3:d887-d912.
27. Mayo MW, Wang CY, Cogswell PC, Rogers-Graham KS, Lowe SW, Der CJ, Baldwin AS, Jr. 1997. Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras. Science 278:1812-1815.
28. Min W, Ghosh S, Lengyel P. 1996. The interferon-inducible p202 protein as a modulator of transcription: Inhibition of NF-kappa B, c-Fos, and c-Jun activities. Mol Cell Biol 16:359-368.
29. Pardee AB. 1989. G1 events and regulation of cell proliferation. Science 246:603-608.
30. Pruitt K, Pestell RG, Der CJ. 2000. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. J Biol Chem 275:40916-40924.
31. Pumiglia KM, Decker SJ. 1997. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94:448-452.
32. Rimoldi D, Samid D, Flessate DM, Friedman RM. 1988. Transcriptional inhibition of Ha-Ras in interferoninduced revertants of Ras-transformed mouse cells. Cancer Res 48:5157-5162.
33. Rozzo SJ, Allard JD, Choubey D, Vyse TJ, Izui S, Peltz G, Kotzin BL. 2001. Evidence for an interferon-inducible gene, Ifi2O2, in the susceptibility to systemic lupus. Immunity 15:435-443.
34. Sakamuro D, Sabbatini P, White E, Prendergast GC. 1997. The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15:887-898.
35. Samid D, Flessate DM, Friedman RM. 1987. Interferoninduced revertants of Ras-transformed cells: Resistance to transformation by specific oncogenes and retransformation by 5-azacytidine. Mol Cell Biol 7:2196-2200.
36. Schlessinger J, Bar-Sagi D. 1994. Activation of Ras and other signaling pathways by receptor tyrosine kinases. Cold Spring Harb Symp Quant Biol 59:173-179.
37. Serrano M, Gomez-Lahoz E, DePinho RA, Beach D, BarSagi D. 1995. Inhibition of Ras-induced proliferation and cellular transformation by p16INK4. Science 267:249-252.
38. Shaulian E, Karin M. 2002. AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136.
39. Wang H, Chatterjee G, Meyer JJ, Liu C-J, Manjunath NA, Bray-Ward P, Lengyel P. 1999. Characteristics of three homologous 202 genes (Ifi202a, Ifi202b, and Ifi202c) from the murine interferon-activatable gene 200 cluster. Genomics 60:281-294.
40. Wang H, Liu CJ, Lu Y, Chatterjee G, Ma XY, Eisenman RN, Lengel P. 2000. The interferon- and differentiationinducible p202a protein inhibits the transcriptional activity of c-Myc by blocking its association with Max. J Biol Chem 275:27377-27385.
41. Wen Y, Yan DH, Spohn B, Deng J, Lin SY, Hung MC. 2000. Tumor suppression and sensitization to tumor necrosis factor alpha-induced apoptosis by an interferon-inducible protein, p202, in breast cancer cells. Cancer Res 60:42-46.
42. Xin H, D'Souza S, Lei F, Lengyel P, Choubey D. 2001. p202, an interferon-inducible negative regulator of cell growth, is a target of the adenovirus E1A protein. Oncogene 20:6828-6839.
43. Yan DH, Wen Y, Spohn B, Choubey D, Gutterman JU, Hung MC. 1999. Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202. Oncogene 18:807-811.